Article
Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis.
Nature communications - 18 Jun 2024
Dintwe One B, Ballweber Fleming Lamar, Voillet Valentin, McNevin John, Seese Aaron, Naidoo Anneta, Omarjee Saleha, Bekker Linda-Gail, Kublin James G, De Rosa Stephen C, Newell Evan W, Fiore-Gartland Andrew, Andersen-Nissen Erica, McElrath M Juliana
Abstract excerpt
A recent clinical trial demonstrated that Bacille Calmette-Guérin (BCG) revaccination of adolescents reduced the risk of sustained infection with Mycobacterium tuberculosis (M.tb). In a companion phase 1b trial, HVTN 602/Aeras A-042, we characterize in-depth the cellular responses to BCG revaccination or to a H4:IC31 vaccine boost to identify T cell subsets that could be responsible for the protection observed....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
